Discharge Medication Use Post-Operatively in GU Cancer Patients

Description

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Conditions

Genitourinary Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Discharge Medication Use Post-Operatively in GU Cancer Patients

Discharge Medication Use Post-Operatively in GU Cancer Patients

Condition
Genitourinary Cancer
Intervention / Treatment

-

Contacts and Locations

Charlotte

Levine Cancer Institute, Charlotte, North Carolina, United States, 28204

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Written informed consent and HIPAA authorization for release of personal health information.
  • 2. Age ≥ 18 years at the time of enrollment
  • 3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
  • 4. Ability to read and understand the English and/or Spanish language.
  • 5. Enrolling investigator plans to prescribe opioids at the time of discharge for post-operative pain.
  • 6. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
  • * None

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Stephen Riggs, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

2026-07